Table 1.
n | Expression level of LRIG1 | P | ||||
---|---|---|---|---|---|---|
− | + | ++ | +++ | |||
Chemosensitive GC | 13 | 4 | 2 | 3 | 4 | <.05 |
Chemoresistant GC | 34 | 19 | 9 | 5 | 1 |
χ2‐tests were used to evaluate the significance of differences in 2 groups.
GC, gastric cancer; LRIG1, leucine‐rich repeats and immunoglobulin‐like domains 1.